Parenteral Drugs (India) (NSE:PDPL) FCF Margin %: 0.00% (As of Mar. 2022)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) FCF Margin %?

Parenteral Drugs (India) NSE:PDPL 4 FCF Margin % is 0.00% as of Mar. 2022. GuruFocus rates NSE:PDPL with a GF Score™ of 4/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Parenteral Drugs (India)'s Free Cash Flow for the three months ended in Mar. 2022 was ₹0.00 Mil. Parenteral Drugs (India)'s Revenue for the three months ended in Mar. 2022 was ₹17.73 Mil. Therefore, Parenteral Drugs (India)'s FCF Margin % for the quarter that ended in Mar. 2022 was 0.00%.

As of today, Parenteral Drugs (India)'s current FCF Yield % is 0.00%.

The historical rank and industry rank for Parenteral Drugs (India)'s FCF Margin % or its related term are showing as below:

NSE:PDPL' s FCF Margin % Range Over the Past 10 Years
Min: -5.68   Med: 0   Max: 0
Current: -5.68

NSE:PDPL's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.445 vs NSE:PDPL: -5.68

Parenteral Drugs (India) FCF Margin % Related Terms

Parenteral Drugs (India) FCF Margin % Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) FCF Margin % Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.28 1,490.81 467.69 -0.91 -5.68

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:PDPL vs ZTS, CTLT, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parenteral Drugs (India) FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s FCF Margin % falls into.


NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Parenteral Drugs (India)'s FCF Margin for the fiscal year that ended in Mar. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=-4.827/84.963
=-5.68 %

Parenteral Drugs (India)'s FCF Margin for the quarter that ended in Mar. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )
=0/17.731
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Parenteral Drugs (India) (NSE:PDPL) has a FCF Margin % of 0.00% as of Mar. 2022. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s FCF Margin % too high?
Parenteral Drugs (India)'s current FCF Margin % is 0.00%. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s FCF Margin % compare to ZTS and CTLT?
Parenteral Drugs (India)'s FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Parenteral Drugs (India) and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Parenteral Drugs (India)'s current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current FCF Margin % is 0.00% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price